Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Denis Ruchnewitz"'
The large-scale evolution of the SARS-CoV-2 virus has been marked by rapid turnover of genetic clades. New variants show intrinsic changes, notably increased transmissibility, as well as anti-genic changes that reduce the cross-immunity induced by pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640199fca4dc486cb13edc1c8aa0a6f8
https://doi.org/10.1101/2022.07.19.500637
https://doi.org/10.1101/2022.07.19.500637
Autor:
Tobias M. Hohl, Chester Poon, N. Esther Babady, Michael Lässig, Deborah Korenstein, Karissa Whiting, Benjamin D. Greenbaum, Tracy McMillen, Denis Ruchnewitz, Suzanne Kelson, Krupa Jani, Kevin P. Browne, Alexander Solovyov, Rebecca S. Guest, Scott Freeswick, Anabella Lucca, Venkatraman E. Seshan, Elizabeth Robilotti, Marta Łuksza, Mini Kamboj
Publikováno v:
Clin Infect Dis
Background Vaccine-induced clinical protection against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) variants is an evolving target. There are limited genomic level data on SARS CoV-2 breakthrough infections and vaccine effectiveness (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4ed37aea4299b57bfc05bb01571c42
https://europepmc.org/articles/PMC9612794/
https://europepmc.org/articles/PMC9612794/
Autor:
Kanika Vanshylla, Chengcheng Fan, Marie Wunsch, Nareshkumar Poopalasingam, Matthijs Meijers, Christoph Kreer, Franziska Kleipass, Denis Ruchnewitz, Meryem S. Ercanoglu, Henning Gruell, Friederike Münn, Kai Pohl, Hanna Janicki, Tobias Nolden, Simone Bartl, Saskia C. Stein, Max Augustin, Felix Dewald, Lutz Gieselmann, Philipp Schommers, Thomas F. Schulz, Leif Erik Sander, Manuel Koch, Marta Łuksza, Michael Lässig, Pamela J. Bjorkman, Florian Klein
Publikováno v:
Cell Host & Microbe
Cell Host Microbe
Cell Host Microbe
A fraction of COVID-19 convalescent individuals mount a potent antibody response to SARS-CoV-2 with cross-reactivity to SARS-CoV-1. To uncover their humoral response in detail, we performed single B-cell analysis from 10 SARS-CoV-2 elite neutralizers